US2826443010 - Common Stock
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader...
It's time to start off trading this morning with a breakdown of the biggest pre-market stock movers worth watching on Tuesday!
EKSO stock results show that Ekso Bionics Holdings missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ekso Bionics Holdings (NASDAQ:EKSO) just reported results for the fourth quarte...
Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq:...
Levi Strauss layoffs are coming for as much as 15% of its corporate workforce as it prepares for a rough economy in 2024!
SU Group stock volatile on Friday following the company's IPO earlier this week with shares currently trading below its debut price.
Aptose Biosciences stock is sliding lower on Friday as investors react to a public offering and private placement for APTO shares.
Ekso Bionics stock is rising higher on Friday without any clear news from the exoskeleton company and no heavy trading activity.
Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning!
Ekso Bionics announces a registered direct offering of common stock, raising $4.6 million for working capital and corporate purposes.
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!
SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
Ekso Bionics expects Q4 2023 revenue of $4.7M-$4.9M and FY2023 revenue of $18.1M-$18.3M. Cash as of Dec 31, 2023, is estimated at $8.6M.
SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso...
Achieves Record Quarter of EVO Unit Sales...
SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...
SAN RAFAEL, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...